Ascendis Pharma (Brazil) Probability of Future Stock Price Finishing Over 54.00
| A1SN34 Stock | BRL 54.00 5.16 10.57% |
Ascendis |
Ascendis Pharma Target Price Odds to finish over 54.00
The tendency of Ascendis Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 54.00 | 90 days | 54.00 | nearly 4.75 |
Based on a normal probability distribution, the odds of Ascendis Pharma to move above the current price in 90 days from now is nearly 4.75 (This Ascendis Pharma AS probability density function shows the probability of Ascendis Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Ascendis Pharma has a beta of 0.71. This suggests as returns on the market go up, Ascendis Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Ascendis Pharma AS will be expected to be much smaller as well. Additionally Ascendis Pharma AS has an alpha of 0.0617, implying that it can generate a 0.0617 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Ascendis Pharma Price Density |
| Price |
Predictive Modules for Ascendis Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ascendis Pharma AS. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Ascendis Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ascendis Pharma is not an exception. The market had few large corrections towards the Ascendis Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ascendis Pharma AS, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ascendis Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.06 | |
β | Beta against Dow Jones | 0.71 | |
σ | Overall volatility | 3.03 | |
Ir | Information ratio | 0.01 |
Ascendis Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ascendis Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ascendis Pharma AS can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ascendis Pharma AS had very high historical volatility over the last 90 days | |
| The company reported the revenue of 7.78 M. Net Loss for the year was (383.58 M) with profit before overhead, payroll, taxes, and interest of 4.25 M. | |
| Ascendis Pharma generates negative cash flow from operations |
Ascendis Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ascendis Stock often depends not only on the future outlook of the current and potential Ascendis Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ascendis Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 56.9 M |
Ascendis Pharma Technical Analysis
Ascendis Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Ascendis Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ascendis Pharma AS. In general, you should focus on analyzing Ascendis Stock price patterns and their correlations with different microeconomic environments and drivers.
Ascendis Pharma Predictive Forecast Models
Ascendis Pharma's time-series forecasting models is one of many Ascendis Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ascendis Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Ascendis Pharma AS
Checking the ongoing alerts about Ascendis Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ascendis Pharma AS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Ascendis Pharma AS had very high historical volatility over the last 90 days | |
| The company reported the revenue of 7.78 M. Net Loss for the year was (383.58 M) with profit before overhead, payroll, taxes, and interest of 4.25 M. | |
| Ascendis Pharma generates negative cash flow from operations |
Additional Information and Resources on Investing in Ascendis Stock
When determining whether Ascendis Pharma AS is a strong investment it is important to analyze Ascendis Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ascendis Pharma's future performance. For an informed investment choice regarding Ascendis Stock, refer to the following important reports:Check out Ascendis Pharma Backtesting, Ascendis Pharma Valuation, Ascendis Pharma Correlation, Ascendis Pharma Hype Analysis, Ascendis Pharma Volatility, Ascendis Pharma History as well as Ascendis Pharma Performance. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.